MX2014007382A - Metodos y composiciones para el tratamiento de deverticulosis. - Google Patents
Metodos y composiciones para el tratamiento de deverticulosis.Info
- Publication number
- MX2014007382A MX2014007382A MX2014007382A MX2014007382A MX2014007382A MX 2014007382 A MX2014007382 A MX 2014007382A MX 2014007382 A MX2014007382 A MX 2014007382A MX 2014007382 A MX2014007382 A MX 2014007382A MX 2014007382 A MX2014007382 A MX 2014007382A
- Authority
- MX
- Mexico
- Prior art keywords
- diverticulosis
- compositions
- treatment
- methods
- glutamine
- Prior art date
Links
- 206010013554 Diverticulum Diseases 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 5
- 239000000203 mixture Substances 0.000 title abstract 4
- 150000008540 L-glutamines Chemical class 0.000 abstract 2
- 230000037396 body weight Effects 0.000 abstract 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 abstract 1
- 229930182816 L-glutamine Natural products 0.000 abstract 1
- 230000037406 food intake Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/24—Cellulose or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/717—Celluloses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/721—Dextrans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/724—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/68—Plantaginaceae (Plantain Family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invención si dirige a métodos y composiciones para el tratamiento de la diverticulosis. Más específicamente se dirige a composiciones que incluyen L-glutamina, sus sales o sus derivados y a los usos de tales composiciones en el tratamiento de la diverticulosis. En un aspecto del método, la presente invención proporciona un método para tratar la diverticulosis. El método incluye la ingestión de 0.05 g/kg de peso corporal a 10.0 g/kg de peso corporal de L-glutamina, una sal de L-glutamina o un derivado de L-glutamina al día, por una persona que presenta diverticulosis.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161630831P | 2011-12-19 | 2011-12-19 | |
| PCT/US2012/000576 WO2013095681A1 (en) | 2011-12-19 | 2012-12-14 | Methods and compositions for the treatment of diverticulosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2014007382A true MX2014007382A (es) | 2014-09-22 |
| MX351688B MX351688B (es) | 2017-10-25 |
Family
ID=48669319
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2014007382A MX351688B (es) | 2011-12-19 | 2012-12-14 | Metodos y composiciones para el tratamiento de deverticulosis. |
Country Status (13)
| Country | Link |
|---|---|
| US (4) | US9616041B2 (es) |
| EP (2) | EP2793875B1 (es) |
| JP (1) | JP6060176B2 (es) |
| KR (4) | KR101848722B1 (es) |
| CN (1) | CN104114165B (es) |
| AU (1) | AU2012355956B2 (es) |
| BR (1) | BR112014014765A8 (es) |
| DK (1) | DK2793875T3 (es) |
| ES (1) | ES2770585T3 (es) |
| IN (1) | IN2014KN01255A (es) |
| MX (1) | MX351688B (es) |
| RU (2) | RU2733396C2 (es) |
| WO (1) | WO2013095681A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CU20200106A7 (es) | 2018-06-20 | 2021-08-06 | Axcella Health Inc | Composiciones y métodos para el tratamiento de hemoglobinopatías y talasemias |
| WO2021010937A1 (en) * | 2019-07-17 | 2021-01-21 | Emmaus Medical, Inc. | Methods and compositions for the treatment of sickle cell diseases and thalassemia |
| US20230053227A1 (en) * | 2021-07-27 | 2023-02-16 | G&S Laboratories, Inc. | Dietary fiber compositions |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2196053T3 (es) * | 1994-01-11 | 2003-12-16 | Stichting Zofia | Procedimiento para el tratamiento de trastornos del cuerpo humano o animal mediante la administracion de aminoacidos. |
| JP2000060487A (ja) * | 1998-08-27 | 2000-02-29 | Kao Corp | 便秘改善剤 |
| US7030092B1 (en) * | 2001-08-24 | 2006-04-18 | Small Giant L.L.C. | Ultra-high fiber supplement and method of reducing weight cardiovascular risks and ingested toxins. |
| US20040005304A1 (en) * | 2002-07-08 | 2004-01-08 | Mak Wood, Inc. | Novel compositions and methods for treating neurological disorders and associated gastrointestinal conditions |
| US20050058671A1 (en) * | 2003-05-09 | 2005-03-17 | Bedding Peter M.J. | Dietary supplement and method for treating digestive system-related disorders |
| US7988989B2 (en) * | 2003-05-09 | 2011-08-02 | Freedom Health, Llc | Nutritional product for enhancing growth and/or strengthening the immune system of equine foals |
| US8512789B2 (en) | 2005-11-23 | 2013-08-20 | The Coca-Cola Company | High-potency sweetener composition with dietary fiber and compositions sweetened therewith |
| US20080003265A1 (en) * | 2006-06-28 | 2008-01-03 | John Francis Casey | Protein and fiber containing dietary supplement |
| PL2086346T3 (pl) * | 2006-11-07 | 2013-06-28 | Procter & Gamble | Kompozycje zawierające błonnik oraz sposoby ich wytwarzania i zastosowanie |
| RU2454730C1 (ru) * | 2011-03-15 | 2012-06-27 | Александр Михайлович Пузиков | Способ лечения дивертикулеза в эксперименте |
-
2012
- 2012-12-14 WO PCT/US2012/000576 patent/WO2013095681A1/en active Application Filing
- 2012-12-14 AU AU2012355956A patent/AU2012355956B2/en active Active
- 2012-12-14 US US13/694,592 patent/US9616041B2/en active Active
- 2012-12-14 KR KR1020177008405A patent/KR101848722B1/ko active IP Right Grant
- 2012-12-14 DK DK12860587.0T patent/DK2793875T3/da active
- 2012-12-14 RU RU2018126834A patent/RU2733396C2/ru active
- 2012-12-14 BR BR112014014765A patent/BR112014014765A8/pt not_active Application Discontinuation
- 2012-12-14 KR KR1020187009799A patent/KR20180039187A/ko not_active Application Discontinuation
- 2012-12-14 EP EP12860587.0A patent/EP2793875B1/en active Active
- 2012-12-14 MX MX2014007382A patent/MX351688B/es active IP Right Grant
- 2012-12-14 RU RU2014123433A patent/RU2662917C2/ru active
- 2012-12-14 JP JP2014547181A patent/JP6060176B2/ja active Active
- 2012-12-14 CN CN201280062802.4A patent/CN104114165B/zh active Active
- 2012-12-14 KR KR1020177020002A patent/KR20170087531A/ko not_active Application Discontinuation
- 2012-12-14 KR KR1020147016785A patent/KR20140103281A/ko active Application Filing
- 2012-12-14 ES ES12860587T patent/ES2770585T3/es active Active
- 2012-12-14 EP EP19199336.9A patent/EP3603631B1/en active Active
-
2014
- 2014-06-10 IN IN1255/KOLNP/2014A patent/IN2014KN01255A/en unknown
-
2017
- 2017-02-10 US US15/530,630 patent/US10258586B2/en active Active
-
2019
- 2019-02-11 US US16/501,039 patent/US11304918B2/en active Active
-
2022
- 2022-03-09 US US17/803,158 patent/US20220202758A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2018000396A (es) | Compuestos aza sustituidos como inhibidores de cinasa 4 asociada al receptor de interleucina 1 (irak-4). | |
| MX351464B (es) | El uso de un agonista del receptor 8 tipo toll para el tratamiento de enfermedades alérgicas. | |
| UA117261C2 (uk) | Похідні карбоксаміду та їх застосування як медикаментів для лікування гепатиту b | |
| PH12020550726A1 (en) | Method and compositions for the treatment of diabetes and related symptoms | |
| SA515360469B1 (ar) | مركبات حلقية غير متجانسة لتثبيط إنزيم جلوتاميناز والطرق الخاصة باستخدامها | |
| PH12014502605A1 (en) | Uracyl spirooxetane nucleosides | |
| UA114531C2 (uk) | Противірусні сполуки проти rsv | |
| JO3091B1 (ar) | مشتقات حمض 3- فنيل بروبيونيك متفرعة واستخداماتها | |
| IN2014DN09370A (es) | ||
| MX2012015292A (es) | Pirazolo[1, 5]pirimidinas en la forma de agentes antivirales. | |
| NZ708928A (en) | Mannose derivatives for treating bacterial infections | |
| TN2014000122A1 (en) | 1 - arylcarbonyl - 4 - oxy - piperidine compounds useful for the treatment of neurodegenerative diseases | |
| SG10201810401RA (en) | Pharmaceutical combinations for treating cancer | |
| MX2015007916A (es) | Peri-carbinoles. | |
| UA110983C2 (uk) | Похідна 1,2,3,4-тетрагідрохіноліну, придатна для лікування діабету | |
| MX2013011691A (es) | Inhibidores de la replicacion viral, su proceso de preparacion y sus usos terapeuticos. | |
| MX2014015185A (es) | Derivados deuterados de ruxolitinib. | |
| MY167898A (en) | Co-crystals and salts of ccr3-inhibitors | |
| MX2013012233A (es) | 4-aril-n-fenil-1,3,5-triazin-2-aminas sustituidas. | |
| MX347842B (es) | Método para la inducción de resistencia a enfermedades en plantas. | |
| MX340033B (es) | Derivados heterobiciclicos como inhibidores del virus de la hepatitis c. | |
| SG10201900541QA (en) | Derivatives of xanthone compounds | |
| EA201690327A1 (ru) | Терапевтические способы | |
| MX2014007382A (es) | Metodos y composiciones para el tratamiento de deverticulosis. | |
| MX2016004909A (es) | Composicion que contiene eugenol como principio activo para prevenir o tratar la dermatitis atopica. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |